Is optimal medical therapy 'optimal therapy' for multivessel coronary artery disease? Optimal management of multivessel coronary artery disease.

摘要

When treating patients with coronary artery disease (CAD), clinicians consider whether management should be medical therapy (MT) alone or in addition to coronary revascularization. When revascularization is recommended, both coronary artery bypass graft surgery (CABG) and percutaneous coronary intervention (PCI) are potential options. Typically, the treatment recommendation is based on clinical presentation, severity and magnitude of ischemia, extent and distribution of coronary anatomic disease, presence of other noncardiac medical conditions, and evidence of the effectiveness of each strategy.